[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601626":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":19,"responsibleParty":36,"collaborators":10,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":40,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":10,"studyType":49,"phases":10,"briefSummary":50,"conditions":51,"keywords":53,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"The Institute of Molecular and Translational Medicine, Czech Republic","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Rectal cancer patients with neoadjuvant chemoradiotherapy",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Rectal cancer patients without neoadjuvant chemoradiotherapy",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Josef Srovnal, Associate professor, MD, PhD","CONTACT","+420 585632137","josef.srovnal@upol.cz",[20],{"facility":21,"status":22,"city":23,"state":10,"zip":10,"country":24,"countryCode":10,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"University Hospital Ostrava","RECRUITING","Ostrava","Czechia",{"type":26,"coordinates":27},"Point",[28,29],18.28204,49.83465,{"lat":29,"lon":28},[32],{"name":33,"role":16,"phone":34,"phoneExt":10,"email":35},"Peter Ihnat, Profesor, MD, PhD.","420 597 375 701","peter.ihnat@fno.cz",{"type":37,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100601626","the-effect-of-multimodal-treatment-of-rectal-cancer-on-circulating-tumor-cells-a-prospective-observational-study-100601626",false,"NCT07112937","The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study","Inclusion Criteria: rectal cancer -\n\nExclusion Criteria: no other cancer\n\n\\-","ALL","18 Years",{"count":47,"type":48},150,"ESTIMATED","OBSERVATIONAL","The prospective study will focus on patients undergoing multimodal treatment for rectal cancer. The main objective of the study will be to monitor changes in circulating tumor cells (CTCs) in the peripheral blood of patients during multimodal treatment. For each patient enrolled in the study, peripheral blood samples will be collected at specified time intervals to determine the presence and quantity of CTCs.\n\nThe CTCs levels will be compared among rectal cancer patients with neoadjuvant chemoradiotherapy and without neoadjuvant chemotherapy.",[52],"Rectal Cancer Patients",[54],"circulating tumor cells","2025-08-01",{"date":57,"type":58},"2025-08-08","ACTUAL",{"date":60,"type":58},"2023-05-02",{"date":62,"type":48},"2027-12-31",{"name":5,"class":6},1]